|
About us
|
How we regulate
|
Safety information
|
Committees
|
Conferences & Learning Centre |
Online services
|
Publications
|
News Centre
|
Your views
|
Main navigation 
Section search
Enter a keyword or phrase to search all pages in this section:
Advanced searchArchive:
Looking for a previously published document in this section?
MDA/2005/063 - Lancing devices - including Roche Accu-Chek Softclix, Softclix II, Softclix Plus and Multiclix lancing devices
Page 1
Ref. MDA/2005/063
Issued: 28 November 2005
| IMMEDIATE ACTION |  |
| ACTION | |
| UPDATE | |
| INFORMATION REQUEST |
| Further Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEVICE:
Lancing devices - including Roche Accu-Chek Softclix, Softclix II, Softclix Plus and Multiclix lancing devices. |
|||||||||||||
|
PROBLEM:
|
> |
||||||||||||
| ACTION BY:
All healthcare and care workers involved in the purchase, supply, provision or use of lancing devices. |
|||||||||||||
| ACTION:
When testing multiple patients, healthcare and care workers should not use single patient lancing devices such as the Roche Accu-Chek Softclix, Softclix II, Softclix Plus or Multiclix lancing devices to obtain blood samples. When obtaining blood samples from more than one patient healthcare and care workers must ensure that the lancing device that they use is intended for this purpose. |
> |
||||||||||||
|
DISTRIBUTED to:
* via CE Bulletin |
> |
||||||||||||
|
CONTACTS:
|
> |
> Further information supplied in the following pages.
MDA/2005/063 - Lancing devices - including Roche Accu-Chek Softclix, Softclix II, Softclix Plus and Multiclix lancing devices.
Page last modified:
28 November 2005
© 2009 Crown Copyright Terms and conditions Links Freedom of information Report a suspected safety problem E-mail alerting service MHRA Portal
General enquiries: 020 7084 2000 info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form.